BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17932867)

  • 1. Vogt-Koyanagi-Harada disease after head trauma.
    Accorinti M; Pirraglia MP; Corsi C; Caggiano C
    Eur J Ophthalmol; 2007; 17(5):847-52. PubMed ID: 17932867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vogt-Koyanagi-Harada disease after stapedotomy.
    Accorinti M; Gilardi M; Nardella C; Amorelli GM; Pesci FR
    Eur J Ophthalmol; 2015 Oct; 25(6):e127-30. PubMed ID: 25982211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vogt-Koyanagi-Harada disease].
    Kjeka O; Krohn J
    Tidsskr Nor Laegeforen; 2005 Aug; 125(16):2195-7. PubMed ID: 16138134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
    Karacorlu M; Arf Karacorlu S; Ozdemir H
    Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vogt-Koyanagi-Harada syndrome in a case of multiple sclerosis.
    Montero JA; Sanchis ME; Fernandez-Munoz M
    J Neuroophthalmol; 2007 Mar; 27(1):36-40. PubMed ID: 17414871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral Iris Depigmentation and Ocular Hypotony as End-Stage Manifestations of Untreated Vogt-Koyanagi-Harada Disease.
    Cuevas M; de-la-Torre A; Córdoba A
    Ocul Immunol Inflamm; 2018; 26(7):1101-1106. PubMed ID: 28548582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and classification of Vogt-Koyanagi-Harada disease.
    Sakata VM; da Silva FT; Hirata CE; de Carvalho JF; Yamamoto JH
    Autoimmun Rev; 2014; 13(4-5):550-5. PubMed ID: 24440284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vogt-Koyanagi-Harada disease.
    O'Keefe GA; Rao NA
    Surv Ophthalmol; 2017; 62(1):1-25. PubMed ID: 27241814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
    Yamanaka E; Ohguro N; Yamamoto S; Nakagawa Y; Imoto Y; Tano Y
    Am J Ophthalmol; 2002 Sep; 134(3):454-6. PubMed ID: 12208266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
    Kim M
    Indian J Ophthalmol; 2016 Jan; 64(1):98. PubMed ID: 26953036
    [No Abstract]   [Full Text] [Related]  

  • 11. Vogt-Koyanagi-Harada syndrome with intracranial meningioma: an as yet unreported association.
    Kumar A; Chhabra MS; Prakash G; Kulkarni AD
    Can J Ophthalmol; 2005 Dec; 40(6):725-8. PubMed ID: 16518897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
    Zhang Q; Fan X; Tian M; Han H
    BMC Nephrol; 2020 Jul; 21(1):272. PubMed ID: 32660433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
    Ikeda N; Hayasaka S; Kadoi C; Nagaki Y
    Ophthalmologica; 1999; 213(3):197-9. PubMed ID: 10202295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
    Hashizume K; Imamura Y; Fujiwara T; Machida S; Ishida M; Kurosaka D
    Retina; 2016 Feb; 36(2):415-21. PubMed ID: 26352553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
    Koong LR; Chee WK; Toh ZH; Ng XL; Agrawal R; Ho SL
    Ocul Immunol Inflamm; 2021 Aug; 29(6):1212-1215. PubMed ID: 34505819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vogt-Koyanagi-Harada syndrome in children].
    Laghmari M; Karim A; Ibrahimy W; Essakalli NH; Mohcine Z
    J Fr Ophtalmol; 2002 Jun; 25(6):636-40. PubMed ID: 12223954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
    Matsuo T; Masuda I; Ota K; Yamadori I; Sunami R; Nose S
    Acta Med Okayama; 2007 Oct; 61(5):305-9. PubMed ID: 17971847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vogt-Koyanagi-Harada disease].
    Bonnet C; Daudin JB; Monnet D; Brézin A
    J Fr Ophtalmol; 2017 Jun; 40(6):512-519. PubMed ID: 28579215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depigmented atrophic lesions in sunset glow fundi of Vogt-Koyanagi-Harada disease.
    Inomata H; Rao NA
    Am J Ophthalmol; 2001 May; 131(5):607-14. PubMed ID: 11336935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.